New On Robinhood

Kronos Bio

$31.57
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.39 (-1.22%) Today
$0.00 (0.00%) As of 9:21 PM UTC after-hours

Why Robinhood?

You can buy or sell Kronos Bio and other stocks, options, and ETFs commission-free!

About KRON

Kronos Bio, Inc. Common Stock, also called Kronos Bio, is a clinical-stage biopharmaceutical, which engages in the provision of discovery and development of novel cancer therapeutics products. Its pipeline includes hematologic transcription factors, small cell, prostate cancer, and MYC-driven cancers. The company was founded by Angela Koehler and Joshua Kazam in 2017 and is headquartered in Cambridge, MA. The listed name for KRON is Kronos Bio, Inc. Common Stock.

CEO
Norbert W. Bischofberger
Employees
45
Headquarters
San Mateo, California
Founded
2017
Market Cap
1.71B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
170.12K
High Today
$32.48
Low Today
$30.54
Open Price
$30.84
Volume
149.52K
52 Week High
$39.61
52 Week Low
$25.50

Collections

KRON Earnings

-$6.48
-$4.32
-$2.16
$0.00
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 18, Pre-Market

You May Also Like

AEB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure